MedTech

breast cancer mammogram
MedTech

SimBioSys nabs FDA OK for AI breast cancer recurrence tool

SimBioSys has been given FDA clearance of the Nvidia-powered TumorSight Risk.
Patrick McGuire Oct 16, 2026 9:00am
graphic of heart shape with stethoscope with computer background

FDA flags Edwards Lifesciences’ mitral valve delivery system

Oct 16, 2026 8:27am
blood test vials

Labcorp, Thrive Global launch latest Thrive 5 health test

Oct 16, 2026 6:56am
AZ

AstraZeneca, insitro ink $1.5B AI-enabled target discovery deal

Oct 15, 2026 6:00am
IPO

Iambic goes public with $150M IPO to accelerate cancer pipeline

Oct 15, 2026 2:30am
Utpal Singh Zealand Pharma

Zealand inks $1.2B Generate pact for anti-obesity protein R&D

Oct 14, 2026 4:08am